Delivery Order SPE2DB22D2007-SPE2DB23FJ2NA
- Not listed
- This federal contract award is for the delivery of the drug Mounjaro (7.5 mg/0.5 ml pen, 0.5 ml) to the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $4,574.47, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price and has an ultimate completion date of May 18, 2023. This contract does not have a set-aside designation, indicating it...
- This federal contract award is for the delivery of the pharmaceutical product Mounjaro 5 mg/0.5 ml pen 0.5 ml to the Defense Logistics Agency (DLA). The contract, valued at $2,587.51, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of May 15, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Mounjaro 5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that is a subsidiary of Cencora, Inc. The contract has a ceiling value of $14,685.54 and an ultimate completion date of May 7, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at up to...
- This federal contract award is for the delivery of the pharmaceutical product Mounjaro 7.5 mg/0.5 ml pen, 0.5 ml. The contract, valued at $9,038.75, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order with a firm fixed price, and the ultimate completion date is July 14, 2025. It is not designated as a set-aside contract, indicating open...
- This federal contract award is for the delivery of Mounjaro (2.5 mg/0.5 ml pen, 0.5 ml) pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $4,275.62 and is a delivery order with a firm fixed price pricing type. The period of performance runs through April 23, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award is for the delivery of the pharmaceutical product Mounjaro 10 mg/0.5 ml pen 0.5 ml to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $20,577.11 and is a firm fixed price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. This contract is not set aside for any specific business type. Amerisourcebergen...
- This federal contract award is for the delivery of Mounjaro 10 mg/0.5 ml pen 0.5ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. The contract is a delivery order with a firm fixed price of $5,260.00 and an ultimate completion date of June 21, 2024. Amerisourcebergen Drug Corp is the sole...
- This federal contract award is for the delivery of Mounjaro 5 mg/0.5 ml pens, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,600.69 Firm Fixed Price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has an ultimate completion date of May 4, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of Mounjaro 5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The award, valued at $2,127.23, was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of the pharmaceutical product Mounjaro 15 mg/0.5 ml pen (0.5 ml) to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,600.54 and an ultimate completion date of December 26, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside....
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB23FJ2NADelivery Order
This federal contract award is for the delivery of Mounjaro 5 mg/0.5 ml pen 0.5 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $11,030.79, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price and a completion date of May 18, 2023. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 5/17/23 |